论文部分内容阅读
目的 探讨超声引导经皮硬化治疗子宫肌瘤的临床应用价值。方法 在 B超实时动态监视下 ,将无水乙醇注入到肌瘤内 ,达到治疗目的。治疗后于 1个月、 2个月、 3个月 B超复查 ,观察疗效。结果 2 8例患者 ,31个肿瘤 ,治疗后 1个月缩小 10 %～ 30 % ,3个月平均缩小 4 9% ,以后观测无改变。观察最长时间为 6年。结论 超声引导下经皮硬化治疗子宫肌瘤是一项操作简便、安全、有效、副作用小、经济的微创治疗技术 ,值得推广应用。
Objective To investigate the clinical value of ultrasound-guided percutaneous sclerosis in the treatment of uterine fibroids. Methods B-ultrasound real-time dynamic monitoring, the anhydrous ethanol injected into the fibroids, to achieve the purpose of treatment. After treatment in 1 month, 2 months, 3 months B-ultrasound, observe the effect. Results Twenty-eight patients and 31 tumors showed a 10% -30% reduction 1 month after treatment and an average reduction of 49% after 3 months. No change was observed afterwards. The longest observation period is 6 years. Conclusion Ultrasound-guided percutaneous sclerosis treatment of uterine fibroids is a simple, safe, effective, with minimal side effects, economical and minimally invasive treatment technology, it is worth to promote the application.